发明名称 HBV immunocomplexes for response prediction and therapy monitoring of chronic HBV patients
摘要 <p>The present invention relates to a method for identifying a subject suffering from hepatitis B virus (HBV) infection as being susceptible to interferon treatment, said method comprising the steps of a) determining, in a sample of said subject, the amount of HBV immune complexes, b) comparing the amount of HBV immune complexes obtained in step a) to a reference value, and c) identifying a subject suffering from HBV infection as being susceptible to interferon treatment based on the result of the comparison made in step b). The present invention further relates to the use of the determination of the amount of HBV immune complexes in a sample from a subject suffering from HBV infection and of a detection agent for HBV immune complexes for identifying a subject suffering from HBV infection as being susceptible to interferon treatment. Furthermore, the present invention relates to a device and a kit allowing identifying a subject suffering from HBV infection as being susceptible to interferon treatment.</p>
申请公布号 EP2629096(A1) 申请公布日期 2013.08.21
申请号 EP20120156192 申请日期 2012.02.20
申请人 ROCHE DIAGNOSTICS GMBH;F. HOFFMANN-LA ROCHE AG 发明人
分类号 G01N33/576;G01N33/68 主分类号 G01N33/576
代理机构 代理人
主权项
地址